Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans

NCT06411366 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Minicircle